Partial penetrance and phenotypic variability of aplasia of lacrimal and salivary glands caused by a novel FGF10 donor splice-site mutation.

ALSG FGF10 aplasia of lacrimal and salivary glands fibroblast growth factor 10 ophthalmology splice site mutation

Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
Nov 2023
Historique:
revised: 11 07 2023
received: 12 04 2023
accepted: 19 07 2023
pubmed: 24 8 2023
medline: 24 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

Thirteen affected individuals of six generations of a single kindred presented with epiphora evident from infancy. Physical exam and Schirmer test revealed variable expression of tear deficiency, congenital punctal atresia, and dry mouth with multiple caries, without concomitant abnormalities of the ears or digits, commensurate with a diagnosis of aplasia of the lacrimal and salivary glands (ALSG). Reconstruction of the upper lacrimal drainage system was performed in some of the affected individuals. Genetic analysis, testing six affected individuals and three non-affected family members, identified a single novel heterozygous splice-site variant, c.429 + 1, G > T in fibroblast growth factor 10 (FGF10) (NM_004465.1), segregating throughout the family as expected for dominant heredity. RT-PCR assays of HEK-293 cells transfected with wild type or mutant FGF10 demonstrated that the variant causes skipping of Exon 2. Notably, individuals sharing the same variant exhibited phenotypic variability, with unilateral or bilateral epiphora, as well as variable expression of dry mouth and caries. Moreover, one of the variant carriers had no ALSG-related clinical findings, demonstrating incomplete penetrance. While coding mutations in FGF10 are known to cause malformations in the nasolacrimal system, this is the second FGF10 splice-site variant and the first donor-site variant reported to cause ALSG. Thus, our study of a unique large kindred with multiple affected individuals heterozygous for the same FGF10 variant highlights intronic splice-site mutations and phenotypic variability/partial penetrance in ALSG.

Identifiants

pubmed: 37615310
doi: 10.1002/ajmg.a.63359
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2768-2774

Subventions

Organisme : Morris Kahn Family Foundation

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Cellntec PEI protocol. (2023). https://cellntec.com/wp-content/uploads/pdf/PEI_Transfection.pdf
Chapman, D. B., Shashi, V., & Kirse, D. J. (2009). Case report: Aplasia of the lacrimal and major salivary glands (ALSG). International Journal of Pediatric Otorhinolaryngology, 73(6), 899-901. https://doi.org/10.1016/J.IJPORL.2009.03.004
Dohlman, J. C., Habib, L. A., & Freitag, S. K. (2019). Punctal agenesis: Embryology, presentation, management modalities and outcomes. Annals of Anatomy-Anatomischer Anzeiger, 224, 113-116. https://doi.org/10.1016/J.AANAT.2019.04.004
Entesarian, M., Dahlqvist, J., Shashi, V., Stanley, C. S., Falahat, B., Reardon, W., & Dahl, N. (2007). FGF10 missense mutations in aplasia of lacrimal and salivary glands (ALSG). European Journal of Human Genetics, 15(3), 379-382. https://doi.org/10.1038/sj.ejhg.5201762
Entesarian, M., Matsson, H., Klar, J., Bergendal, B., Olson, L., Arakaki, R., Hayashi, Y., Ohuchi, H., Falahat, B., Bolstad, A. I., Jonsson, R., Wahren-Herlenius, M., & Dahl, N. (2005). Mutations in the gene encoding fibroblast growth factor 10 are associated with aplasia of lacrimal and salivary glands. Nature Genetics, 37(2), 125-127. https://doi.org/10.1038/NG1507
Ento Key Congenital or acquired punctal atresia and canaliculus closure. (2023). https://entokey.com/congenital-or-acquired-punctal-atresia-and-canaliculus-closure/
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A., 3rd, & Smith, H. O. (2009). Enzymatic assembly of DNA molecules up to several hundred kilobases. Nature Methods, 6(5), 12-16. https://doi.org/10.1038/NMETH.1318
Halperin, D., Dolgin, V., Geylis, M., Drabkin, M., Yogev, Y., Wormser, O., Schreiber, R., Shalev, H., Landau, D., & Birk, O. S. (2019). A novel SLC12A1 mutation in Bedouin kindred with antenatal Bartter syndrome type I. Annals of Human Genetics, 83, 361-366. https://doi.org/10.1111/ahg.12317
Nasolacrimal System Anatomy Embryology, puncta, canaliculi. (2023). https://emedicine.medscape.com/article/835092-overview
ProQuest Familial absence of lacrimal puncta associated with preauricular sinuses. (2023). https://www.proquest.com/docview/222208905?parentSessionId=SyPpQaRkBagfwkdIu4uhR7STCwdVBYMT%2FVtHEBVF2Ko%3D&pq-origsite=primo&accountid=14484
Rodrigo, M. J., Idoipe, M., Izquierdo, S., Satue, M., Mateo, A., Sanchez, A., Garcia-Martin, E., & Pablo, L. (2017). New pathogenic variant in the FGF10 gene in the agenesis of lacrimal and salivary gland syndrome: Ophthalmological and genetic study. Ophthalmic Genetics, 39(1), 125-128. https://doi.org/10.1080/13816810.2017.1381976
Rohmann, E., Brunner, H. G., Kayserili, H., Uyguner, O., Nürnberg, G., Lew, E. D., Dobbie, A., Eswarakumar, V. P., Uzumcu, A., Ulubil-Emeroglu, M., Leroy, J. G., Li, Y., Becker, C., Lehnerdt, K., Cremers, C. W. R. J., Yüksel-Apak, M., Nürnberg, P., Kubisch, C., Schlessinger, J., … Wollnik, B. (2006). Mutations in different components of FGF signaling in LADD syndrome. Nature Genetics, 38, 414-417. https://doi.org/10.1038/ng1757
Scheckenbach, K., Balz, V., Wagenmann, M., & Hoffmann, T. K. (2008). An intronic alteration of the fibroblast growth factor 10 gene causing ALSG-(aplasia of lacrimal and salivary glands) syndrome. BMC Medical Genetics, 9(1), 1-10. https://doi.org/10.1186/1471-2350-9-114/FIGURES/4
Seymen, F., Koruyucu, M., Toptanci, I. R., Balsak, S., Dedeoglu, S., Celepkolu, T., Shin, T. J., Hyun, H. K., Kim, Y. J., & Kim, J. W. (2017). Novel FGF10 mutation in autosomal dominant aplasia of lacrimal and salivary glands. Clinical Oral Investigations, 21(1), 167-172. https://doi.org/10.1007/S00784-016-1771-X/FIGURES/5
Watson, J., & Francavilla, C. (2018). Regulation of FGF10 signaling in development and disease. Frontiers in Genetics, 9, 500. https://doi.org/10.3389/FGENE.2018.00500/BIBTEX
Zhang, X., Ibrahimi, O. A., Olsen, S. K., Umemori, H., Mohammadi, M., & Ornitz, D. M. (2006). Receptor specificity of THE fibroblast growth factor family: The complete Mammalian FGF family. The Journal of Biological Chemistry, 281(23), 15694-15700. https://doi.org/10.1074/JBC.M601252200

Auteurs

Ofek Freund (O)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev, Beer-Sheva, Israel.
The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Baker Elsana (B)

Department of Ophthalmology, Soroka Medical Center, Beer-Sheva, Israel.
Clalit Health Services, Affiliated to the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Nadav Agam (N)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev, Beer-Sheva, Israel.
The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Matan M Jean (MM)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev, Beer-Sheva, Israel.
The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Amit Safran (A)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev, Beer-Sheva, Israel.
The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Tomer Poleg (T)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev, Beer-Sheva, Israel.
The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Nir Roguin (N)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev, Beer-Sheva, Israel.
The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Libe Gradstein (L)

Department of Ophthalmology, Soroka Medical Center, Beer-Sheva, Israel.
Clalit Health Services, Affiliated to the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Erez Tsumi (E)

Department of Ophthalmology, Soroka Medical Center, Beer-Sheva, Israel.
Clalit Health Services, Affiliated to the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Ohad S Birk (OS)

The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev, Beer-Sheva, Israel.
The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Genetics Institute, Soroka University Medical Center, Affiliated to Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Classifications MeSH